3:47 PM
 | 
Nov 01, 2018
 |  BC Extra  |  Company News

Illumina taking out Pacific Biosciences for $1.2B

Illumina Inc. (NASDAQ:ILMN) is acquiring fellow genomics company Pacific Biosciences of California (NASDAQ:PACB) for $8 per share in cash, or about $1.2 billion.

The price is...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >